A new target for treatment of one type of macular degeneration
A new study in mice hints at the promise of an eventual alternative treatment option for the "wet" version of age-related macular degeneration (AMD).
Jul 2, 2024
0
0
A new study in mice hints at the promise of an eventual alternative treatment option for the "wet" version of age-related macular degeneration (AMD).
Jul 2, 2024
0
0
Tumors depend heavily on certain genetic changes to thrive, and researchers have discovered many such "genetic dependencies" as targets for potential new cancer drugs. At the Broad Institute of MIT and Harvard and elsewhere, ...
Jan 23, 2024
0
0
On Aug. 4, 2023, the United States Food and Drug Administration (FDA) approved zuranolone (Zurzuvae) as the first oral neurosteroid treatment for postpartum depression (PPD) in women.
Oct 20, 2023
0
1
In Parkinson's disease, growing evidence targets neuroinflammation as essential for brain pathogenesis. But which group of immune cells that reside in the brain direct this inflammatory response?
Aug 9, 2023
0
12
A clinical trial led by the National Cancer Institute (NCI), part of the National Institutes of Health, has resulted in the first approval of a treatment for advanced alveolar soft part sarcoma (ASPS). The immunotherapy drug ...
Dec 28, 2022
0
44
The Ph.D. research of Yuan Feng focuses on promoting the well-being of a vulnerable population in our society—people with dementia—using interactive technologies. Collaborating with the Vitalis Berckelhof, a Dutch residential ...
Jul 11, 2022
0
7
When soldiers go into combat, they put themselves at risk of a traumatic brain injury (TBI), which is caused by a bump, blow or jolt to the head. Explosions experienced during combat or training exercises can cause a soldier's ...
Mar 17, 2022
0
98
The brain is constantly firing and controlling purposeful action potentials—electronic messages used by neurons to communicate with each other and allow the brain to function. Conversely, the way spontaneous neural communication ...
Feb 15, 2022
0
7
Using a newly developed mouse model of acute lung injury, researchers found that exposure to the SARS-CoV-2 spike protein alone was enough to induce COVID-19-like symptoms including severe inflammation of the lungs.
Apr 27, 2021
7
3297
Vanderbilt pharmacologists have reported the first evidence that aberrant spontaneous release of neurotransmitters in the brain can cause a range of severe intellectual and neurodevelopmental disorders in infants and children.
Nov 4, 2020
0
37